Evidence Summary
What is an Evidence Summary?
Key messages from scientific research that's ready to be acted on
Got It, Hide thisLow-dose aspirin does not reduce cognitive impairment in older adults
Veronese N, Stubbs B, Maggi S, et al. Low-Dose Aspirin Use and Cognitive Function in Older Age: A Systematic Review and Meta-analysis. J Am Geriatr Soc. 2017;65:1763-8.
Review question
In older adults who do not have cognitive impairment or dementia, does low-dose aspirin slow cognitive impairment?
Background
As people age, it is natural for memory to get worse. Mild cognitive impairment can include problems with thinking, memory, language, and judgment that are noticeable. Dementia is more serious cognitive impairment that interferes with daily living. Many people use low-dose aspirin to prevent cardiovascular diseases. Since cardiovascular diseases are risk factors for cognitive impairment and dementia, it is possible that aspirin might prevent or slow worsening of cognitive function.
How the review was done
The researchers did a systematic review, searching for studies that were published up to September 2016. They found 3 randomized controlled trials with 10,037 people who were, on average, 67 years of age. 74% were women. People were followed for 3 to 10 years.
The key features of the studies were as follows:
- people in the trials did not have cognitive impairment or dementia;
- treatment was low-dose aspirin, less than 300 mg/day;
- low-dose aspirin was compared with placebo or no aspirin for at least 1 year; and
- the outcome was cognitive function.
What the researchers found
The quality of the trials was good.
People who took aspirin did not differ from those who did not for global cognitive test scores and verbal memory scores.
Low-dose aspirin improved executive function (ability to manage time, pay attention, switch focus) and fluency (ability to speak accurately and quickly) test scores.
More people who used low-dose aspirin had stomach-related adverse effects.
Conclusion
In people who do not have cognitive impairment or dementia, taking low-dose aspirin does not reduce cognitive impairment.
Low-dose aspirin vs placebo or no aspirin in people who do not have cognitive impairment or dementia
| Outcomes | Effect of low-dose aspirin |
| Global cognitive test scores | No differences between groups. |
| Verbal memory tests | No differences between groups. |
| Executive function and fluency tests | Low-dose aspirin improved scores. |
| Adverse effects | Low-dose aspirin increased stomach-related side-effects. |
Glossary
Mental processes, including thinking, learning and remembering.
Trouble remembering, learning new things, concentrating, or making decisions that affect everyday life.
A harmless, inactive, and simulated treatment.
Studies where people are assigned to one of the treatments purely by chance.
Aspects making a condition more likely.
A comprehensive evaluation of the available research evidence on a particular topic.
The body's network of blood vessels. It includes the arteries, veins, and capillaries that carry blood to and from the heart.
Related Evidence Summaries
-
Tai Chi can improve cognitive function in older adults with cognitive impairment and healthy older adults
Journal of the American Geriatrics Society (2014) -
The evidence is unclear about whether it is better for older adults to receive long-term care through home and community-based services or in a nursing home
Agency for Healthcare Research and Quality (2012) -
Computerised cognitive training for 12 or more weeks for maintaining cognitive function in cognitively healthy people in late life.
Cochrane Database Syst Rev (2020)
Register for free access to all Professional content
RegisterOur Content
About
Support for the Portal is largely provided by the Labarge Optimal Aging Initiative. AGE-WELL is a contributing partner. Help us to continue to provide direct and easy access to evidence-based information on health and social conditions to help you stay healthy, active and engaged as you grow older. Donate Today.
